HCW Biologics (HCWB) Institutional Ownership $0.43 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for HCW Biologics (NASDAQ:HCWB)CurrentInstitutional OwnershipPercentage2.96%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$368.89KNumber ofInstitutional Sellers(last 12 months)0 Get HCWB Insider Trade Alerts Want to know when executives and insiders are buying or selling HCW Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here HCW Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2024 Pullen Investment Management LLC85,116$149K0.1%N/A0.225% 2/9/2024Avantax Planning Partners Inc.179,541$220K0.0%N/A0.499% 2/9/2023HighTower Advisors LLC269,869$517K0.0%+19.6%0.752% 11/15/2021HighTower Advisors LLC14,000$45K0.0%N/A0.039% (Data available from 1/1/2016 forward) HCWB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HCWB shares? During the previous two years, the following institutional investors and hedge funds held shares of HCW Biologics shares: HighTower Advisors LLC ($517K), and Avantax Planning Partners Inc. ($220K), Pullen Investment Management LLC ($149K).Learn more on HCWB's institutional investors. What percentage of HCW Biologics stock is owned by institutional investors? 2.96% of HCW Biologics stock is owned by institutional investors. Learn more on HCWB's institutional investor holdings. Which institutional investors have been buying HCW Biologics stock? The following institutional investors have purchased HCW Biologics stock in the last 24 months: Avantax Planning Partners Inc. ($179.54K), Pullen Investment Management LLC ($85.12K), and HighTower Advisors LLC ($44.27K). How much institutional buying is happening at HCW Biologics? Institutional investors have bought a total of 308,928 shares in the last 24 months. This purchase volume represents approximately $453.66K in transactions. Related Companies T2 Biosystems Institutional Ownership Enlivex Therapeutics Institutional Ownership Vistagen Therapeutics Institutional Ownership Ikena Oncology Institutional Ownership IO Biotech Institutional Ownership Aileron Therapeutics Institutional Ownership InterCure Institutional Ownership Protalix BioTherapeutics Institutional Ownership Elutia Institutional Ownership Chimerix Institutional Ownership This page (NASDAQ:HCWB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
